Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Individualized treatments may help manage Dercum's disease symptoms.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Pexidartinib often causes liver issues and fatigue, especially in women.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Recognizing unusual skin, eye, or hair issues can help diagnose immune system disorders early, especially in children.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Baricitinib may effectively treat oral lichen planus.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.